FGFR2 and breast carcinoma: In a recent study, FGFR1 and p53 mutation was associated with central nervous system (CNS) metastases in a breast cancer patient cohort [108] and FGFR2 amplification was reported as a clonal event in CNS metastases in a warm autopsy series [111].